Vivos (RDGL) Return on Capital Employed (2011 - 2025)
Vivos (RDGL) posted Return on Capital Employed of 161.19% for Q4 2025, down 42.99% sequentially from 112.73% in Q3 2025, and down 361.0% YoY from 61.76% in Q4 2024.
Vivos (RDGL) Return on Capital Employed (2011 - 2025) Analysis & Trends
Vivos has reported Return on Capital Employed for 15 years, with the latest figure at 161.19% in Q4 2025.
- Quarterly Return on Capital Employed fell 361.0% year-over-year to 161.19% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 161.19% (down 361.0% YoY) and the FY2025 annual result came in at 163.77%, down 2189.0% from the prior year.
- Return on Capital Employed slipped to 161.19% in Q4 2025 per RDGL's latest filing, from 112.73% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 75.62% in Q1 2021 and troughed at 219.63% in Q1 2024.
- A 5-year average of 156.53% and a median of 153.6% in 2021 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2021 and 2025: Return on Capital Employed slumped 31454 bps in 2021, then surged 11064 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 149.62% in 2021, then rose by 7 bps to 138.89% in 2022, then plunged by 50 bps to 207.93% in 2023, then advanced by 24 bps to 157.59% in 2024, then declined by 2 bps to 161.19% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 161.19%, 112.73%, and 103.43% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 | -161.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -161.19% |
| Sep 30, 2025 | -112.73% |
| Jun 30, 2025 | -103.43% |
| Mar 31, 2025 | -108.99% |
| Dec 31, 2024 | -157.59% |
| Sep 30, 2024 | -197.88% |
| Jun 30, 2024 | -193.68% |
| Mar 31, 2024 | -219.63% |
| Dec 31, 2023 | -207.93% |
| Sep 30, 2023 | -162.73% |
| Jun 30, 2023 | -141.81% |
| Mar 31, 2023 | -129.96% |
| Dec 31, 2022 | -138.89% |
| Sep 30, 2022 | -143.38% |
| Jun 30, 2022 | -196.20% |
| Mar 31, 2022 | -217.54% |
| Dec 31, 2021 | -149.62% |
| Sep 30, 2021 | -169.77% |
| Jun 30, 2021 | -142.05% |
| Mar 31, 2021 | -75.62% |